Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences
AUSTIN, Texas, Sept. 22, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer, will provide a corporate overview at the Ladenburg Thalmann 2017 Healthcare Conference, and the Cantor Fitzgerald Global Healthcare Conference.
Ladenburg Thalmann Healthcare Conference
Date: Tuesday, September 26
Time: 1:30pm Eastern Time
Location: Sofitel Hotel New York, Odeon Ballroom
Cantor Fitzgerald Healthcare Conference
Date: Wednesday, September 27
Time: 4:35pm Eastern Time
Location: InterContinental New York Barclay Hotel, Empire Ballroom 2
About Molecular Templates
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases. For additional information, please visit Molecular Templates’ website at www.mtem.com.
Andrew McDonald, Ph.D.
Released September 22, 2017